NYSE:WST West Pharmaceutical Services (WST) Stock Price, News & Analysis $375.99 +5.55 (+1.50%) Closing price 03:59 PM EasternExtended Trading$373.94 -2.05 (-0.54%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About West Pharmaceutical Services Stock (NYSE:WST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get WST alerts:Sign Up Key Stats Today's Range$366.55▼$378.4750-Day Range$328.61▼$375.9952-Week Range$223.83▼$386.00Volume562,272 shsAverage Volume585,302 shsMarket Capitalization$26.46 billionP/E Ratio48.14Dividend Yield0.23%Price Target$382.00Consensus RatingModerate Buy Company Overview West Pharmaceutical Services, Inc. (NYSE: WST) develops and manufactures components and systems used to package, contain and deliver injectable medicines and other healthcare products. Its customers include pharmaceutical, biotechnology and medical device companies, which use West products in drug administration and medical applications. The company’s offerings include elastomer components such as stoppers, plungers and seals; syringe and cartridge components; vial and container closure systems; and specialized delivery systems for injectable and other complex medicines. West also provides contract-manufactured products and device solutions, including systems designed to support self-administration and other drug-delivery applications. Founded in 1923, West Pharmaceutical Services is headquartered in Exton, Pennsylvania, and serves customers through manufacturing, development and commercial operations across North America, Europe and Asia. Its business is organized around proprietary products and contract-manufactured products, with a focus on supporting the pharmaceutical and healthcare supply chains.AI Generated. May Contain Errors. Read More West Pharmaceutical Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreWST MarketRank™: West Pharmaceutical Services scored higher than 58% of companies evaluated by MarketBeat, and ranked 358th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.6 / 5Analyst RatingModerate Buy Consensus RatingWest Pharmaceutical Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on no strong buy ratings, 12 buy ratings, 2 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for West Pharmaceutical Services is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageWest Pharmaceutical Services has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about West Pharmaceutical Services' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth10.86% Earnings GrowthEarnings for West Pharmaceutical Services are expected to grow by 10.86% in the coming year, from $8.93 to $9.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of West Pharmaceutical Services is 48.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.82.Price to Earnings Ratio vs. SectorThe P/E ratio of West Pharmaceutical Services is 48.14, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.05.Price to Earnings Growth RatioWest Pharmaceutical Services has a PEG Ratio of 2.59. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioWest Pharmaceutical Services has a P/B Ratio of 8.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about West Pharmaceutical Services' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.40% of the float of West Pharmaceutical Services has been sold short.Short Interest Ratio / Days to CoverWest Pharmaceutical Services has a short interest ratio ("days to cover") of 4.51.Change versus previous monthShort interest in West Pharmaceutical Services has recently increased by 8.31%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldWest Pharmaceutical Services has a dividend yield of 0.24%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthWest Pharmaceutical Services does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of West Pharmaceutical Services is 11.27%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 8.89% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.Read more about West Pharmaceutical Services' dividend. News and Social Media2.5 / 5News Sentiment1.01 News SentimentWest Pharmaceutical Services has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for West Pharmaceutical Services this week, compared to 6 articles on an average week.Search InterestOnly 4 people have searched for WST on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added West Pharmaceutical Services to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, West Pharmaceutical Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,443,749.00 in company stock.Percentage Held by Insiders0.60% of the stock of West Pharmaceutical Services is held by insiders.Percentage Held by Institutions93.90% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about West Pharmaceutical Services' insider trading history. Receive WST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WST Stock News HeadlinesWest Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 25 at 2:15 AM | americanbankingnews.comWest Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley SaysSeptember 22, 2026 | finance.yahoo.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 28 at 1:00 AM | Stansberry Research (Ad)Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)September 20, 2026 | finance.yahoo.comWhat Is Drawing Attention To West Pharmaceutical Services (WST)?September 20, 2026 | finance.yahoo.comIs West Pharmaceutical Services Stock Outperforming the Nasdaq?September 17, 2026 | finance.yahoo.comWest Pharmaceutical Services (NYSE:WST) VP Sells 2,500 SharesSeptember 16, 2026 | insidertrades.comInsider Selling: West Pharmaceutical Services (NYSE:WST) VP Sells 8,135 Shares of StockSeptember 11, 2026 | insidertrades.comSee More Headlines WST Stock Analysis - Frequently Asked Questions How have WST shares performed this year? West Pharmaceutical Services' stock was trading at $275.53 at the beginning of 2026. Since then, WST stock has increased by 36.5% and is now trading at $375.9870. How were West Pharmaceutical Services' earnings last quarter? West Pharmaceutical Services, Inc. (NYSE:WST) posted its quarterly earnings results on Thursday, July, 23rd. The medical instruments supplier reported $2.37 EPS for the quarter, topping the consensus estimate of $2.08 by $0.29. The firm's revenue was up 13.8% compared to the same quarter last year. Read the conference call transcript. How will West Pharmaceutical Services' stock buyback program work? West Pharmaceutical Services' Board of Directors authorized a stock repurchase program on Tuesday, February 17th 2026, which allows the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 5.6% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's leadership believes its shares are undervalued. Does West Pharmaceutical Services have any subsidiaries? West Pharmaceutical Services subsidiaries include Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., The Tech Group Inc., Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), TGPR Holdings Limited, WD SG Pte. Ltd., and others. Who are West Pharmaceutical Services' major shareholders? Top institutional shareholders of West Pharmaceutical Services include BlackRock Inc. (9.45%), State Street Corp (4.76%), Bank of New York Mellon Corp (2.90%) and Generation Investment Management LLP (2.88%). Insiders that own company stock include Eric Mark Green, Thomas W Hofmann, Annette F Favorite, Silji Abraham, Chad Winters and Charles Witherspoon. View institutional ownership trends. How do I buy shares of West Pharmaceutical Services? Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of West Pharmaceutical Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that West Pharmaceutical Services investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Home Depot (HD), Chevron (CVX) and Netflix (NFLX). Company Calendar Last Earnings7/23/2026Record date for 8/5 Dividend7/29/2026Ex-Dividend for 8/5 Dividend7/29/2026Dividend Payable8/05/2026Today9/28/2026Next Earnings (Estimated)10/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 WST's financial health is in the Green zone, according to TradeSmith. WST has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNYSE:WST CIK105770 Webwww.westpharma.com Phone(610) 594-2900Fax800-345-9800Employees10,800Year Founded1923Price Target and Rating Average Price Target for West Pharmaceutical Services$382.00 High Price Target$447.00 Low Price Target$295.00 Potential Upside/Downside+1.6%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$7.81 Trailing P/E Ratio48.14 Forward P/E Ratio42.10 P/E Growth2.59Net Income$493.70 million Net Margins16.98% Pretax Margin20.85% Return on Equity20.11% Return on Assets14.83% Debt Debt-to-Equity Ratio0.07 Current Ratio2.82 Quick Ratio2.12 Sales & Book Value Annual Sales$3.07 billion Price / Sales8.61 Cash Flow$9.88 per share Price / Cash Flow38.04 Book Value$44.10 per share Price / Book8.53Miscellaneous Outstanding Shares70,380,000Free Float69,954,000Market Cap$26.46 billion OptionableOptionable Beta1.14 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NYSE:WST) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share West Pharmaceutical Services With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WST Stock Alerts